T Cell Prolymphocytic Leukemia (T-PLL): Cutaneous Involvement in an Uncommon Leukemia

被引:0
|
作者
Kakkar, Naveen [1 ]
Calton, Nalini [1 ]
John, M. Joseph [2 ]
机构
[1] Christian Med Coll & Hosp, Dept Pathol, Brown Rd, Ludhiana 141008, Punjab, India
[2] Christian Med Coll & Hosp, Dept Clin Haematol Hematooncol & Bone Marrow Stem, Ludhiana 141008, Punjab, India
关键词
Cell Prolymphocytic Leukemia; Scant Basophilic Cytoplasm; Epidermotropism; Myeloid Hematopoietic Cells; Developed Tumour Lysis Syndrome;
D O I
10.1007/s12288-018-0932-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:573 / 574
页数:2
相关论文
共 50 条
  • [31] Allogeneic Hematopoietic Cell Transplantation (allo-HCT) in T-Cell Prolymphocytic Leukemia (T-PLL): An Analysis from the CIBMTR
    Murthy, Hemant S.
    Ahn, Kwang Woo
    Estrada-Merly, Noel
    Gowda, Lohith
    Dholaria, Bhagirathbhai
    Bal, Susan
    Alkhateeb, Hassan B.
    Jagadeesh, Deepa
    Oran, Betul
    Nakamura, Ryotaro
    Scott, Bart L.
    Sauter, Craig S.
    Foss, Francine M.
    Kharfan-Dabaja, Mohamed A.
    Saber, Wael
    BLOOD, 2020, 136
  • [32] CUTANEOUS INFILTRATION IN T-CELL PROLYMPHOCYTIC LEUKEMIA
    MALLETT, RB
    MATUTES, E
    CATOVSKY, D
    MACLENNAN, K
    MORTIMER, PS
    HOLDEN, CA
    BRITISH JOURNAL OF DERMATOLOGY, 1995, 132 (02) : 263 - 266
  • [33] Cutaneous Presentation of T-Cell Prolymphocytic Leukemia
    Ventre, Marie O.
    Bacelieri, Rocky E.
    Lazarchick, John
    Pollack, Ross B.
    Metcalf, John S.
    CUTIS, 2013, 91 (02): : 87 - 91
  • [34] Skin involvement in T-cell prolymphocytic leukemia
    Herling, Marco
    Valbuena, Lose R.
    Jones, Dan
    Medeiros, L. Jeffrey
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 57 (03) : 533 - 534
  • [35] Broad single-cell characterization of T-cell prolymphocytic leukemia (T-PLL) identifies functional subclones for precise therapeutic targeting
    Pemovska, T.
    Pichler, A.
    Wahnschaffe, L.
    Timonen, S. H.
    Mustjoki, S.
    Herling, M.
    Staber, P. B.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 105 - 105
  • [36] CDK9 Inhibition with LDC526 Is an Effective Treatment for T-Cell Prolymphocytic Leukemia (T-PLL) in Vitro
    Johansson, Patricia
    Habenberger, Peter
    Klein-Hitpass, Ludger
    Duehrsen, Ulrich
    Kuppers, Ralf
    Schultz-Fademrecht, Carsten
    Choidas, Axel
    Durig, Jan
    BLOOD, 2017, 130
  • [37] “T-cell prolymphocytic leukemia (T-PLL), a heterogeneous disease exemplified by two cases and the important role of cytogenetics: a multidisciplinary approach”
    Carlos A Tirado
    Phillip Starshak
    Paul Delgado
    Nagesh Rao
    Experimental Hematology & Oncology, 1 (1)
  • [38] Clinical, Pathological, and Genetic Characteristics of T-Cell Prolymphocytic Leukemia (T-PLL) in a Less Aggressive Course: A Single Institutional Experience
    Idrees, Afshan
    Horna, Pedro
    Sokol, Lubomir
    Zhang, Ling
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2014, 142
  • [39] Genomic profiling of T-cell Prolymphocytic Leukemia (T-PLL) identifies novel recurrent mutations in SAMHD1 and PTPRC
    Johansson, P.
    Klein-Hitpass, L.
    Bergmann, A.
    Siebert, R.
    Scholtysik, R.
    Przekopowitz, M.
    Seifert, M.
    Zenz, T.
    Duehrsen, U.
    Kueppers, R.
    Duerig, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 238 - 238
  • [40] T-Cell Prolymphocytic Leukemia (T-PLL) with t(X;14)(q28; q11.2): A Report of 17 Cases
    Hu, Zhihong
    Xu, Mina
    Yuan, Ji
    Peker, Deniz
    Shao, Lina
    Rios, Adan
    Medeiros, L. Jeffrey
    Hu, Shimin
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 844 - 844